In-Person Access Only | 4.75 CE/CME Credits & MOC Points
Please read: All programs remain free. Registrations will require a credit card as a cancellation hold. A fee of $25 will only be incurred in the event of a no-show or cancellation within 5 days without written confirmation to the Total Health Program Team. Industry representatives—defined as any individual who is employed by, contracted with, owns, or represents a drug, device, diagnostic, or other healthcare-related commercial entity, regardless of clinical credentials or licensure—are not permitted to attend Total Health events as general attendees. Members of industry must contact exhibits@totalhealthoncology.com
The 3rd Annual NYC Pancreatic Cancer Consortium, held in New York City, will bring together leading experts across disciplines to address the growing clinical and scientific challenges in the management of pancreatic cancer. This symposium is dedicated to advancing a collaborative, multidisciplinary approach to pancreatic oncology, with a focus on improving outcomes through innovation, research, and team-based care.
This year’s program will feature speakers from Cold Spring Harbor, Columbia University Medical Center, Mount Sinai, Stony Brook University, Weill Cornell Medicine, Memorial Sloan Kettering Cancer Center, and NYU Langone, in addition to Northwell Health Cancer Institute.
Program Chairs:
Matthew Weiss, MD (Northwell Health Cancer Institute)
Danielle DePeralta, MD (Northwell Health Cancer Institute)
Dave Tuveson, MD (Cold Spring Harbor Laboratory)
Conference Agenda
Friday, November 13, 2026
7:30 AM
Breakfast and Exhibits
8:00 AM
Welcome & Introduction
Matthew Weiss, MD | Northwell Health Cancer Institute
Danielle DePeralta, MD | Northwell Health Cancer Institute
Dave Tuveson, MD | Cold Spring Harbor Laboratory
8:15 AM - 9:00 AM
Non-CME Breakfast - Ipsen - NALIRIFOX first for metastatic pancreatic adenocarcinoma
Raji Shameem, MD | Orlando Health Cancer Institute
9:00 - 9:50 AM
CASE-BASED DISCUSSION I: LOCALLY ADVANCED PANCREATIC CANCER
Moderator: Karyn Goodman, MD | Mount Sinai
Management of Biliary and Duodenal Obstruction in Non-Surgical Patients - Seung Eun (Grace) Lee, MD | Memorial Sloan Kettering Cancer Center
Neoadjuvant Therapy for Borderline and Locally Advanced PDAC and Modulation of the Adenosine Signaling Pathway - Linda Wu, MD | Columbia University Medical Center
Intra-Arterial Therapy for Locally Advanced Pancreatic Cancer
Surgical Resection for Locally Advanced PDAC: Patient Selection and Long-Term Outcomes - John Chabot, MD | Columbia University Medical Center
9:50 - 10:20 AM
Break and Exhibits
10:20 - 11:10 AM
CASE-BASED DISCUSSION II: METASTATIC PANCREATIC CANCER
Moderator: Paul Oberstein, MD | NYU Langone
Moderator: Despina Siolas, MD | Weill Cornell Medicine
Therapeutic Development to Stop Pancreatic Cancer Metastasis - Nancy Du, PhD | Weill Cornell Medicine
Biomarkers Circulating Tumor DNA (ctDNA) - Sofya Pintova, MD | Mount Sinai
Landscape of Potentially Practice Changing Trials for Metastatic Pancreatic Cancer - Daniel King, MD | Northwell Health Cancer Institute
Endoscopic Management of Complications in the Metastatic Patient - Kartik Sampath, MD | Weill Cornell Medicine
11:10 - 11:20 AM
Break and Exhibits
11:20 - 11:55 AM
ROBOTIC PANCREAS SURGERY: INNOVATIVE TECHNIQUES AND FUTURE OF AI INTEGRATION
Moderator: Steve Cohen, MD | Northwell Health Cancer Institute
Moderator: Brock Hewitt, MD | NYU Langone
Panelist: Kevin Soares, MD | Memorial Sloan Kettering Cancer Center
Updates in Robotic Whipple - Alice Wei, MD | Memorial Sloan Kettering Cancer Center
Where Are We Going, Opportunities for Artificial Intelligence and Future of Surgical Care - James Park, MD | Mount Sinai
11:55 AM - 12:25 PM
KEYNOTE PRESENTATION: Response and Resistance to RAS Inhibitors in Pancreatic Cancer
Brian Wolpin, MD, MPH | Dana-Farber Cancer Institute
12:25 - 12:40 PM
Lunch and Exhibits
12:40 - 1:25 PM
Non-CME Lunch - Revolution Medicines
1:25 - 2:00 PM
PATIENT & CAREGIVER PERSPECTIVE (ACP SESSION): WHAT WE WISH WE KNEW EARLIER AND WHAT WE WISH OUR CLINICAL TEAM KNEW
Moderator: Meghan Rayder, NP | Northwell Health Cancer Institute
Panelist: Angie Ortiz Rubiano, RN, BSN | Stony Brook
2:00 - 2:55 PM
CASE-BASED DISCUSSION III: PANCREATIC NEUROENDOCRINE TUMORS (PNET)
Moderator: Riya Patel, MD | Northwell Health Cancer Institute
Moderator: Danielle DePeralta, MD | Northwell Health Cancer Institute
Is There a Role for Endoscopic Ablation of Small PNET?
Evolving Systemic Therapy for Advanced PNETs
Shrinking the Boundaries: The Role of Surgery in Patients with Metastatic PNETs
Theranostics in PNETs: Where are We Now and What’s on the Horizon?
2:55 - 3:45 PM
GENETIC / HEREDITARY HIGH-RISK PANCREATIC CANCER
Moderator: Fay Kastrinos, MD | Columbia University Medical Center
Moderator: Meera Bhardwaj, MD | Stony Brook
Patient Experience in a Surveillance Program: Does Screening Create Unnecessary Anxiety? - Kara Raphael, MD | Northwell Health Cancer Institute
Lessons from Longitudinal Imaging: What Are We Missing During Surveillance? - Chenchan Huang, MD | NYU Langone
Is Screening Effective in High-Risk Patients? - Vineet Rolston, MD | Memorial Sloan Kettering Cancer Center
Pancreatic Cancer Screening in High-risk Diabetes - Richard Frank, MD | Northwell Health Cancer Institute
3:45 - 4:15 PM
Closing Remarks & Adjourn
4:15 - 5:15 PM
Networking Cocktail Reception
Agenda Subject To Change. All times are EST.
-
Review and analyze advances in the multi-modality treatment of pancreatic cancer including newly available clinical trials.
Identify specific clinical trials available to pancreatic cancer patients at different stages of their disease process.
Describe specific molecular or genetic mutations found in pancreatic cancers that would indicate use of specific medications to treat the disease.
-
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health Conferencing. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Nurses (ANCC) Credit Designation
Amedco LLC designates this activity for a maximum of 6.5 ANCC contact hours.
Physicians (ACCME) Credit Designation
Amedco LLC designates this live activity for a maximum of 6.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacists and Pharmacy Technicians (ACPE) Credit Designation
Amedco LLC designates this activity for a maximum of 6.5 knowledge-based CPE contact hours.
-
Free registration for all healthcare providers
Expert sessions that present the most clinically relevant data, research, and clinical strategies
Real-time discussion and debate
Networking with peers, colleagues, and medical professionals
Access to the latest industry information and resources
Catered meals through-out the program